297 related articles for article (PubMed ID: 15661024)
41. Gene therapy of severe combined immunodeficiencies: from mice to humans.
Hacein-Bey S; Yates F; de Villartay JP; Fischer A; Cavazzana-Calvo M
Neth J Med; 2002 Aug; 60(7):299-301. PubMed ID: 12430581
[No Abstract] [Full Text] [Related]
42. Population-based newborn screening for severe combined immunodeficiency: steps toward implementation.
Puck JM;
J Allergy Clin Immunol; 2007 Oct; 120(4):760-8. PubMed ID: 17931561
[TBL] [Abstract][Full Text] [Related]
43. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
44. Gene therapy for primary immunodeficiencies.
Fischer A; Hacein-Bey Abina S; Touzot F; Cavazzana M
Clin Genet; 2015 Dec; 88(6):507-15. PubMed ID: 25708106
[TBL] [Abstract][Full Text] [Related]
45. Successful unrelated mismatched cord blood transplantation in an infant with severe combined immunodeficiency and Mycobacterium bovis bacillus Calmette-Guèrin disease.
Jaing TH; Lee WI; Lin TY; Huang JL; Chen SH; Chow R
Pediatr Transplant; 2006 Jun; 10(4):501-4. PubMed ID: 16712611
[TBL] [Abstract][Full Text] [Related]
46. [Human peripheral blood CD4+ T-lymphocytes reconstituting severe combined immunodeficient mouse-human cell immune system and its immunological function].
Zeng QH; Wang W; Liu T; Shi Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):513-6. PubMed ID: 16137035
[TBL] [Abstract][Full Text] [Related]
47. Improving immune reconstitution while preventing GvHD in allogeneic stem cell transplantation.
André-Schmutz I; Dal Cortivo L; Fischer A; Cavazzana-Calvo M
Cytotherapy; 2005; 7(2):102-8. PubMed ID: 16040389
[TBL] [Abstract][Full Text] [Related]
48. Rapid full engraftment and successful immune reconstitution after allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in Omenn syndrome.
Gozdzik J; Czogala W; Skoczen S; Krasowska-Kwiecien A; Wiecha O; Mordel A; Lesko E; Majka M; Kowalczyk D; Zembala M
Pediatr Transplant; 2009 Sep; 13(6):760-5. PubMed ID: 18992055
[TBL] [Abstract][Full Text] [Related]
49. Late immunologic and clinical outcomes for children with SCID.
Neven B; Cavazanna-Calvo M; Fischer A
Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):76-8. PubMed ID: 19418624
[No Abstract] [Full Text] [Related]
50. Hematopoietic stem cell transplantation for severe combined immune deficiency or what the children have taught us.
Rappeport JM; O'Reilly RJ; Kapoor N; Parkman R
Hematol Oncol Clin North Am; 2011 Feb; 25(1):17-30. PubMed ID: 21236387
[TBL] [Abstract][Full Text] [Related]
51. [Umbilical cord blood as a source of stem cells].
Bojanić I; Golubić Cepulić B
Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
[TBL] [Abstract][Full Text] [Related]
52. Omenn syndrome: a lack of tolerance on the background of deficient lymphocyte development and maturation.
Hönig M; Schwarz K
Curr Opin Rheumatol; 2006 Jul; 18(4):383-8. PubMed ID: 16763459
[TBL] [Abstract][Full Text] [Related]
53. Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency.
Palmer K; Green TD; Roberts JL; Sajaroff E; Cooney M; Parrott R; Chen DF; Reinsmoen NL; Buckley RH
J Allergy Clin Immunol; 2007 Aug; 120(2):423-8. PubMed ID: 17481714
[TBL] [Abstract][Full Text] [Related]
54. Outcome of hematopoietic stem cell transplantation in severe combined immune deficiency with central nervous system viral infection.
Waruiru C; Slatter MA; Taylor C; Ramesh V; Flood TJ; Abinun M; Cant AJ; Gennery AR
Pediatr Infect Dis J; 2007 Feb; 26(2):129-33. PubMed ID: 17259874
[TBL] [Abstract][Full Text] [Related]
55. Newborn screening for T-cell deficiency.
Chase NM; Verbsky JW; Routes JM
Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):521-5. PubMed ID: 20864885
[TBL] [Abstract][Full Text] [Related]
56. Optimizing outcomes of hematopoietic stem cell transplantation for severe combined immunodeficiency.
Cuvelier GD; Schultz KR; Davis J; Hirschfeld AF; Junker AK; Tan R; Turvey SE
Clin Immunol; 2009 May; 131(2):179-88. PubMed ID: 19217351
[TBL] [Abstract][Full Text] [Related]
57. [Inborn immunodeficiencies].
Müller-Hermelink HK; Müller J
Verh Dtsch Ges Pathol; 1991; 75():32-50. PubMed ID: 1724840
[TBL] [Abstract][Full Text] [Related]
58. Severe combined immunodeficiency--an update.
Cirillo E; Giardino G; Gallo V; D'Assante R; Grasso F; Romano R; Di Lillo C; Galasso G; Pignata C
Ann N Y Acad Sci; 2015 Nov; 1356():90-106. PubMed ID: 26235889
[TBL] [Abstract][Full Text] [Related]
59. Screening for severe combined immunodeficiency in newborns.
Shearer WT
J Allergy Clin Immunol; 2012 Mar; 129(3):619-21. PubMed ID: 22277197
[No Abstract] [Full Text] [Related]
60. Severe Combined Immunodeficient (SCID) Mice in Vaccine Assessment.
Dennis MJ
Methods Mol Med; 2003; 87():313-34. PubMed ID: 12958465
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
